Home › Alopecia Areata › NCT05745389
CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
RecruitingObservational study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * A subject must meet all the following criteria to participate in the registry: 1. Has been diagnosed with alopecia areata by a dermatologist or a qualified dermatology practitioner. 2. Is at least 18 years of age or older. 3. Is willing to provide Personal Information. 4. Is prescribed or starting an Enrollment Eligible Medication at the time of enrollment. Exclusion Criteria: * Any of the following would exclude the subject from participating in the registry: 1. Is participating or planning to participate in a double-blind randomized trial for an AA drug. Note: Concurrent participation in another observational registry or open-label Phase 3b/4 trial is allowed.
About the study
Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.
Sponsor: CorEvitas · Participants: 5,000 · Started: Oct 25, 2022
Contact the study team
- Cathy Cheney · Phone: (508) 408-5435
- Resham Sanzagiri · Phone: 508-948-0898
Official record on ClinicalTrials.gov — NCT05745389
Locations in the U.S.
| Massachusetts | CorEvitas, LLC, Waltham |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.